Lescat M, Dupeyron C, Faubert E, Mangeney N
Laboratoire de Microbiologie, Hôpital Albert Chenevier, 40 rue de Mesly, 94000 Creteil, France.
J Hosp Infect. 2004 Jul;57(3):253-7. doi: 10.1016/j.jhin.2004.02.008.
Methicillin-resistant Staphylococcus aureus (MRSA) susceptible strains to aminoglycosides (AS-MRSA) have been increasingly isolated in the Albert Cheneiver Hospital during the past 10 years. The aim of this study was first, to analyse the genotypes and the profiles of resistance to antibiotics and second to compare the AS-MRSA with the MRSA resistant to gentamicin (GR-MRSA) and with MRSA resistant to kanamycin and tobramycin, but susceptible to gentamicin (GS-MRSA), previously studied in our laboratory. All the AS-MRSA consecutively isolated from clinical samples (carriage isolates excluded) from 01/01/1993 to 31/12/2002 (33 isolates) were typed by DNA macrorestriction. Their susceptibilities to other anti-staphylococcal drugs (erythromycin, lincomycin, tetracycline, rifampicin, fusidic acid and fosfomycin) were studied by the French standard disk method. The 33 strains showed a heterogeneous resistance to oxacillin and fell into five phenotypes. The main phenotype (51.5% of the AS-MRSA strains) was susceptible to the six antibiotics studied. DNA macrorestriction defined 24 genotypes (percentage similarity <80%). Among them 16 genotypes contained only one strain each, and none contained more than three isolates. Conversely the comparison with GR-MRSA and GS-MRSA isolated during the same period showed that the strains were not closely linked. The diversity of our isolates showed that it was not an epidemic phenomenon, in contrast to the results of similar studies. Our findings may be explained by the patients coming mostly from different hospital units. This work indicates the need for further studies on the genome, to determine whether AS-MRSA have derived from strains that occurred before aminoglycosides came into clinical use.
在过去10年里,阿尔贝·谢内弗医院越来越多地分离出对氨基糖苷类敏感的耐甲氧西林金黄色葡萄球菌(AS-MRSA)。本研究的目的首先是分析其基因型和抗生素耐药谱,其次是将AS-MRSA与对庆大霉素耐药的MRSA(GR-MRSA)以及对卡那霉素和妥布霉素耐药但对庆大霉素敏感的MRSA(GS-MRSA)进行比较,GS-MRSA此前已在我们实验室进行过研究。对1993年1月1日至2002年12月31日期间从临床样本中连续分离出的所有AS-MRSA(不包括携带菌株)(共33株)进行DNA宏观限制性分型。通过法国标准纸片法研究它们对其他抗葡萄球菌药物(红霉素、林可霉素、四环素、利福平、夫西地酸和磷霉素)的敏感性。这33株菌株对苯唑西林表现出异质性耐药,分为五种表型。主要表型(占AS-MRSA菌株的51.5%)对所研究的六种抗生素敏感。DNA宏观限制性分析确定了24种基因型(百分比相似度<80%)。其中16种基因型每种仅包含一株菌株,且没有一种包含超过三株分离株。相反,与同期分离出的GR-MRSA和GS-MRSA的比较表明,这些菌株之间没有密切联系。与类似研究结果相反,我们分离株的多样性表明这不是一种流行现象。我们的研究结果可能是由于患者大多来自不同的医院科室。这项工作表明有必要对基因组进行进一步研究,以确定AS-MRSA是否源自氨基糖苷类药物进入临床使用之前出现的菌株。